188 related articles for article (PubMed ID: 19742337)
41. Trends in screening for colorectal cancer--United States, 1997 and 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(9):162-6. PubMed ID: 11393486
[TBL] [Abstract][Full Text] [Related]
42. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
[TBL] [Abstract][Full Text] [Related]
43. Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):193-6. PubMed ID: 12653456
[TBL] [Abstract][Full Text] [Related]
44. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
45. Trends in colorectal cancer testing among Medicare subpopulations.
Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
[TBL] [Abstract][Full Text] [Related]
46. [Necessity and feasibility of screening for colorectal cancer in China].
Zhang SZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
[TBL] [Abstract][Full Text] [Related]
47. Performance of a colorectal cancer screening protocol in an economically and medically underserved population.
Cai SR; Zhang SZ; Zhu HH; Huang YQ; Li QR; Ma XY; Yao KY; Zheng S
Cancer Prev Res (Phila); 2011 Oct; 4(10):1572-9. PubMed ID: 21952582
[TBL] [Abstract][Full Text] [Related]
48. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.
UK Colorectal Cancer Screening Pilot Group
BMJ; 2004 Jul; 329(7458):133. PubMed ID: 15237087
[TBL] [Abstract][Full Text] [Related]
49. Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia.
Lane JM; Chow E; Young GP; Good N; Smith A; Bull J; Sandford J; Morcom J; Bampton PA; Cole SR
Gastroenterology; 2010 Dec; 139(6):1918-26. PubMed ID: 20723544
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
[No Abstract] [Full Text] [Related]
51. "It's a small price to pay for life": faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators.
Reeder AI
N Z Med J; 2011 Mar; 124(1331):11-7. PubMed ID: 21725408
[TBL] [Abstract][Full Text] [Related]
52. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.
Li S; Wang H; Hu J; Li N; Liu Y; Wu Z; Zheng Y; Wang H; Wu K; Ye H; Rao J
Int J Cancer; 2006 Jun; 118(12):3078-83. PubMed ID: 16425283
[TBL] [Abstract][Full Text] [Related]
53. Predictive power of quantitative and qualitative fecal immunochemical tests for hemoglobin in population screening for colorectal neoplasm.
Huang Y; Li Q; Ge W; Cai S; Zhang S; Zheng S
Eur J Cancer Prev; 2014 Jan; 23(1):27-34. PubMed ID: 23942476
[TBL] [Abstract][Full Text] [Related]
54. Extent of prevalence and size of flat neoplasms in a heterogeneous population undergoing routine colorectal cancer screening.
Kim J; Rami P; O'Toole J; Llor X; Carroll RE; Benya RV
Colorectal Dis; 2010 May; 12(5):471-6. PubMed ID: 19298579
[TBL] [Abstract][Full Text] [Related]
55. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
[No Abstract] [Full Text] [Related]
56. [The effect of immunofecal occult blood test on colorectal cancer screening].
Yang HY; Ge ZZ; Dai J; Li XB; Gao YJ
Zhonghua Nei Ke Za Zhi; 2008 Aug; 47(8):642-5. PubMed ID: 19080296
[TBL] [Abstract][Full Text] [Related]
57. An academic medical center model for community colorectal cancer screening: the Centers for Disease Control and Prevention demonstration program experience.
Lane DS; Cavanagh MF; Messina CR; Anderson JC
Acad Med; 2010 Aug; 85(8):1354-61. PubMed ID: 20453811
[TBL] [Abstract][Full Text] [Related]
58. Psychological distress following fecal occult blood test in colorectal cancer screening--a population-based study.
Brasso K; Ladelund S; Frederiksen BL; Jørgensen T
Scand J Gastroenterol; 2010 Oct; 45(10):1211-6. PubMed ID: 20443744
[TBL] [Abstract][Full Text] [Related]
59. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database.
Brenner H; Altenhofen L; Katalinic A; Lansdorp-Vogelaar I; Hoffmeister M
Am J Epidemiol; 2011 Nov; 174(10):1140-6. PubMed ID: 21984657
[TBL] [Abstract][Full Text] [Related]
60. Screening for colorectal cancer.
Guittet L; Launoy G
N Engl J Med; 2010 Jan; 362(1):84-5; author reply 85. PubMed ID: 20054054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
